维普中文期刊产品整合服务
68篇 您的检索式:作者名="MAUREEN L"
    题名 作者 年代 出处 被引量
1Breastfeeding rates and hospital breastfeeding practices in Canada: A national survey of women显示文摘Beverley C Cheryl L Maureen H 2009BIRTH2009,36,2:1
2Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study显示文摘Douglas S Berkman Andres G Lescano Robert H Gilman Sonia L Lopez Maureen M Black 2002The Lancet2002,,9306:1
3Effects of age and intentionality on content memory and temporal memory for performed activities 显示文摘Maureen S E Amy L S 2001Aging Neuropsychology and Cognition2001,8,2:1
4smith, Determinants of Sport Commitment Among Junior Tennis Players: Enjoyment as a Mediating Variable显示文摘Maureen R Weiss Lissa A Kimmel Alan L 2001Pediatric Exercise Science2001,13,:1
5Prior Develop- ment and validation of an improved oxygen radical absorbance ca- pacity assay using fluorescein as the fluorescent probe 显示文摘Boxin Ou Maureen Hampsch-Woodill Ronald L 2001Agric food chem2001,49,10:1
6Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding显示文摘Joseph L Kim Kurt A Morgenstern James P Griffith Maureen D Dwyer John A Thomson Mark A Murcko Chao Lin Paul R Caron 1998Structure1998,,1:1
7HPLC/UV quantitation of retinal,retinol,and retinyl esters in serum and tissues显示文摘Maureen A K Alexandra E F Joseph L N 2008Anal Biochem2008,378,1:1
8Helicobacter infection: pathogenesis显示文摘Thomas G Blanchard Maureen L Steven J 2004Curr Opin Gastroenterol2004,20,1:1
9早期乳腺癌最佳辅助化疗方案与人类表皮生长因子受体2阳性乳腺癌辅助靶向治疗选择:依据 ASCO 对 CCO临床实践指南的改编显示文摘目的研究加拿大安大略癌症治疗中心(CCO)关于早期乳腺癌最佳辅助化疗方案,包括人类表皮生长因子受体2(HER2)阳性乳腺癌辅助靶向治疗方案,并对其进行改编。方法按照美国临床肿瘤协会(ASCO)对其他组织临床实践指南改编的策略和程序,对CCO临床实践指南的严谨性与内容适用性进行回顾。结果基于对CCO临床实践指南内容的回顾,ASCO小组认为,CCO临床实践指南在整体上清晰全面,以最确切的科学证据为基础,为患者提供可接受的治疗选项。推荐关于辅助化疗方案的决定,应考虑到基线复发风险、毒性、利益可能性和宿主因素(如合并症)。对于高风险HER2阴性的身体状况良好的人群,蒽环类和紫杉烷治疗方案是标准治疗方案。4个周期的多西他赛和环磷酰胺治疗方案是可接受的非蒽环类治疗方案。对于高风险HER2阳性患者,推荐蒽环类与紫杉烷序贯疗法联合曲妥单抗或多西他赛、卡铂、曲妥单抗进行6个周期的治疗。对于低风险、非淋巴结转移、HER2阳性人群,推荐每周一次的紫杉醇和曲妥单抗连续进行12个周期的替代治疗。曲妥单抗应持续使用1年。不应采用铂复合盐对三阴性人群进行常规的辅助管理,除非出现有效的生存数据加以支持。Neelima Denduluri Mark R Somerfield Andrea Eisen Jamie N Holloway Arti Hurria Tari A King Gary H Lyman Ann H Partridge Melinda L Telli Maureen E Trudeau Antonio C Wolff 本刊编辑部 2016中国全科医学2016,19,18:1
10Effect of diets of varying energy concentration on growth of geese显示文摘MAUREEN L S 1982Poultry Sci1982,61,:1
11The influence of type Ⅰ collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: Modification of expression of genes supporting cell growth, adhesion, and extraeellular matrix mineralization 显示文摘Maureen P Lynch Janet L 1995Experinmental cell research1995,216,:1
12Ambrose, Old Friends, New Faces: Motivation Research in the 1990s 显示文摘MAUREEN L 1999Journal of Management1999,,3:1
13Statistical significance of freeze-thaw related factors on cumulative damage to flexible pavements 显示文摘Kestler Maureen A Berg Richard L Bigl Susan R 2011Trans- portation Research Record2011,2232,:1
14One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy显示文摘Richard S Kaiser Maureen G Maguire Juan E Grunwald Douglas Lieb Binoy Jani Alexander J Brucker Albert M Maguire Allen C Ho Stuart L Fine 2000American Journal of Ophthalmology2000,,2:1
15The effect of fasting time of mature,no -laying female emblem geese on true metabolizable energy of corn显示文摘Story Maureen L 1982Poult Sci1982,61,:1
16Impact of conditioning regimen on peripheral blood hematopoietic cell transplant显示文摘AIM To investigate infused hematopoietic cell doses and their interaction with conditioning regimen intensity +/-total body irradiation(TBI) on outcomes after peripheral blood hematopoietic cell transplant(PBHCT).METHODS Our retrospective cohort included 247 patients receiving a first, T-replete, human leukocyte antigen-matched allogeneic PBHCT and treated between 2001 and2012. Correlations were calculated using the Pearson product-moment correlation coefficient. Overall survival and progression free survival curves were generated using the Kaplan-Meier method and compared using the log-rank test.RESULTS Neutrophil engraftment was significantly faster after reduced intensity TBI based conditioning [reduced intensity conditioning(RIC) + TBI] and > 4 × 10~6 CD34+cells/kg infused. A higher total nucleated cell dose led to a higher incidence of grade II-IV acute graft-versus-host disease in the myeloablative + TBI regimen group(P = 0.03), but no significant difference in grade III-IV graft-versus-host disease. A higher total nucleated cell dose was also associated with increased incidence of moderate/severe chronic graft-versus-host disease, regardless ofconditioning regimen. Overall and progression-free survival were significantly better in patients with a RIC + TBI regimen and total nucleated cell dose > 8 ×10~8/kg(3 years, overall survival: 70% vs 38%, P = 0.02, 3 years, progression free survival: 64% vs 38%, P = 0.02).CONCLUSION TBI and conditioning intensity may alter the relationship between infused cell doses and outcomes after PBHCT. Immune cell subsets may predict improved survival after unmanipulated PBHCT.Michael Burns Anurag K Singh Carrie C Hoefer Yali Zhang Paul K Wallace George L Chen Alexis Platek Timothy B Winslow Austin J Iovoli Christopher Choi Maureen Ross Philip L McCarthy Theresa Hahn 2019World Journal of Clinical Oncology2019,10,2:1
17How well do their dietary patterns meet the healthy people 2010 objectives显示文摘CHERYL L PERRY PHD MAUREEN T 2002Archives of Pediatrics & Adolescent Medicine2002,156,:1
18Abstinence and review of US policies and programs显示文摘John S Mary A Maureen abstinenceonly education:A L 2006Add Health2006,38,1:1
19Effect of Mixer Geo- metry and Operating Conditions on Mixing Efficiency of a Non-Newtonian Fluid in a Twin Screw Mixer显示文摘Maureen L Rathod Jozef L 2013Journal of Food Engineering2013,118,:1
20Metabolites from an antarctic sponge-associated bacterium Pseudomonasae ruginosa 显示文摘Jayatilake G S Maureen P T Alan C L 1996J Nat Prod1996,59,3:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费